Jason N. Butler
Stock Analyst at JMP Securities
(2.62)
# 2,198
Out of 4,966 analysts
4
Total ratings
75%
Success rate
12.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGEN Precigen | Maintains: Market Outperform | $6 → $8 | $4.51 | +77.38% | 1 | Aug 19, 2025 | |
| ZVRA Zevra Therapeutics | Maintains: Market Outperform | $19 → $18 | $9.07 | +98.46% | 1 | Aug 13, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $30 → $35 | $25.99 | +34.67% | 1 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Market Outperform | $91 → $78 | $73.15 | +6.63% | 1 | Aug 6, 2025 |
Precigen
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $4.51
Upside: +77.38%
Zevra Therapeutics
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $9.07
Upside: +98.46%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Market Outperform
Price Target: $30 → $35
Current: $25.99
Upside: +34.67%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $73.15
Upside: +6.63%